Provided by Tiger Trade Technology Pte. Ltd.

Corgi U.S. Healthcare 2x Daily ETF

31.15
-0.1214-0.39%
Post-market: 31.460.3056+0.98%16:10 EDT
Volume:4K
Turnover:112.74K
Market Cap:623.07K
PE:- -
High:31.86
Open:31.85
Low:31.15
Close:31.27
52wk High:35.56
52wk Low:25.40
Shares:20.00K
Float Shares:20.00K
Volume Ratio:3.32
T/O Rate:17.82%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Femasys announces FDA approval of FemBloc modular premarket approval application

TIPRANKS
·
Aug 19

My Son Does not Work, yet Pays $500 for Affordable Care Act Health Insurance. is That Fair?

Dow Jones
·
Aug 18

Amylyx Phase 3 data support FDA approval, says Citi

TIPRANKS
·
Aug 18

'It's a Double-Edged Sword': My Husband Got a $42,000 Bonus. Will it Wipe Out Our Affordable Care Act Subsidy?

Dow Jones
·
Aug 18

My Son Does not Work, yet Pays $500 for Affordable Care Act Health Insurance. is That Fair?

Dow Jones
·
Aug 17

'It's a Double-Edged Sword': My Husband Got a $42,000 Bonus. Will it Wipe Out Our Affordable Care Act Subsidy?

Dow Jones
·
Aug 17

Health Insurers are Dumping Medicare Advantage Plans. Here's How Many Seniors Could be Affected.

Dow Jones
·
Aug 16

The Bull Case For Alignment Healthcare (ALHC) Could Change Following Its Top Medicare Advantage Pick Recognition

Simply Wall St.
·
Aug 15

'It's a Double-Edged Sword': My Husband Got a $42,000 Bonus. Will it Wipe Out Our Affordable Care Act Subsidy?

Dow Jones
·
Aug 15

'It's a Double-Edged Sword': My Husband Got a $42,000 Bonus. Will it Wipe Out Our Affordable Care Act Subsidy?

Dow Jones
·
Aug 14

Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks

TIPRANKS
·
Aug 13

As Insurers Flee Medicare Advantage, Here's How Many Seniors May be Affected

Dow Jones
·
Aug 12

Health Insurers are Dumping Medicare Advantage Plans. Here's How Many Seniors Could be Affected.

Dow Jones
·
Aug 12

3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy

TIPRANKS
·
Aug 11

Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1

TIPRANKS
·
Aug 06

Clover Health reports Q2 EPS 5c vs. (2c) last year

TIPRANKS
·
Aug 06

Clover Health sees FY26 revenue $2.92B-$3.00B, consensus $2.91B

TIPRANKS
·
Aug 06

Fresenius announces FDA approval of rituximab biosimilar

TIPRANKS
·
Aug 04

Rising Medicare Part D Premiums Could Drive More People into Medicare Advantage Plans

Dow Jones
·
Aug 02

Rising Part D Premiums Could Drive More People into Medicare Advantage Plans

Dow Jones
·
Jul 30